Pharmacological agonists of α7nAChR, which activate the inflammatory reflex, are being developed as potential anti-inflammatory therapies, with promising results in experimental models for sepsis and surgical injury [2,3,19]. The gene discussed is CHRNA7; the disease is Sepsis.